Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
Research grant on health disparities in Latin America for NCDs, focusing on clinical epidemiology and policy evaluation, requiring collaboration with Latin American institutions.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 5, 2025 | June 5, 2025 | October 5, 2025 | February 5, 2026 | June 5, 2026 | October 5, 2026
Funding Amounts: No budget limit; budgets must reflect actual needs. Maximum project period: 5 years.
Summary: Supports collaborative research to address health and healthcare disparities in non-communicable and chronic diseases in Latin America and among U.S. Hispanics/Latinos.
Key Information: Applications must include at least one PI or MPI from a Latin America-based institution; clinical trials are not allowed.
Description
This NIH funding opportunity supports innovative, collaborative, and multidisciplinary research focused on clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements addressing health and healthcare disparities related to non-communicable and chronic diseases (NCDs) with the highest burden and mortality in Latin America and among U.S. Hispanics/Latinos. The program emphasizes meaningful partnerships between U.S.-based and Latin America-based investigators, with the expectation that at least one PI or MPI is affiliated with a Latin American institution.
Research teams are encouraged to focus on diseases such as obesity, diabetes, cardiovascular and cerebrovascular diseases, hypertension, cancer, chronic lung disease, kidney disease, liver disease, cognitive impairment, dementia, and mental/behavioral health conditions, among others. Projects may also address interpersonal violence, social determinants of health, and health system or policy interventions.
The majority of research activities and budget (approximately 70%) should be directed to Latin America-based institutions, with U.S.-based institutions (including Puerto Rico) serving as the award recipients. Studies must be conducted in Spanish-speaking Latin American countries or Puerto Rico, and applications must demonstrate strong, equitable collaboration with local investigators and stakeholders.
Clinical trials are not permitted under this opportunity.
